ORIC
Oric Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.72
+3.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.38
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 3, 2026
- EPS actual
- -$0.38
- EPS estimate
- -$0.36
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $26
- PT range
- $26 – $27
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 3, 2026 | -$0.36 | -$0.38 | Miss -5.75% | — |
| May 4, 2026 | -$0.31 | -$0.34 | Miss -9.68% | — |
| Nov 13, 2025 | -$0.41 | -$0.33 | Beat 19.51% | — |
| Feb 18, 2025 | -$0.52 | -$0.51 | Beat 1.92% | $533.0K |
| Mar 11, 2024 | -$0.49 | -$0.49 | In line | $1.5M |
| Aug 10, 2023 | -$0.58 | -$0.50 | Beat 13.79% | — |
| Mar 16, 2023 | -$0.56 | -$0.52 | Beat 7.14% | — |
| Aug 11, 2022 | -$0.60 | -$0.51 | Beat 15.00% | — |
| Mar 21, 2022 | -$0.61 | -$0.58 | Beat 4.92% | — |
| Aug 10, 2021 | -$0.50 | -$0.57 | Miss -14.00% | — |
| May 6, 2021 | -$0.48 | -$0.45 | Beat 6.25% | — |
| Mar 23, 2021 | -$0.50 | -$0.84 | Miss -68.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026